Why the study?
LRP1 is associated with coronary artery disease, but its genotype-specific association with all-cause and cardiovascular mortality from a gender perspective had not been evaluated.
Does the LRP1 (rs1466535) T/T or C/T genotype increase all-cause and cardiovascular mortality in elderly community-living people?
Cohort (n=489)
No
Does the LRP1 (rs1466535) T/T or C/T genotype increase all-cause and cardiovascular mortality in elderly community-living people?
Effect estimate: HR 5.61 (95% CI 1.98-15.85)
p-value: p=0.001
The LRP1 rs1466535 T/T or C/T genotypes are associated with a significantly increased risk of cardiovascular and all-cause mortality in elderly females, highlighting a potential gender-specific genetic risk factor.
May support targeted genetic studies in elderly women; leaves open clinical utility of LRP1 genotyping pending validation.
Cardiovascular diseases are an important health resource problem and studies have shown a genetic association between single nucleotide polymorphisms (SNPs) and cardiovascular diseases. According to the literature, lipoprotein receptor-related protein 1 (LRP1) is associated with coronary artery disease. The aim of the present study was to evaluate a possible association between different genotypes of LRP1 and all-cause and cardiovascular mortality from a gender perspective. In the present study, 489 elderly community-living people were invited to participate. Clinical examination, echocardiography and blood sampling including SNP analyses of LRP1 (rs1466535) were performed, including the T/T, C/T and C/C genotypes, and the participants were followed for 6.7 years. During the follow-up period, 116 (24%) all-cause and 75 (15%) cardiovascular deaths were registered. In the female population, the LRP1 of the T/T or C/T genotype exhibited a 5.6-fold increased risk of cardiovascular mortality and a 2.8-fold increased risk of all-cause mortality compared with the C/C genotype. No such genotype differences could be seen in the male population. Gender differences could be seen regarding the risk of mortality in the different genotypes. Females with the LRP1 T/T or C/T genotypes exhibited a significantly increased risk of both all-cause and cardiovascular mortality compared with the C/C genotypes. Therefore, more individualized cardiovascular prevention and treatment should be prioritized. However, since this was a small study, the observations should only be regarded as hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Alehagen et al. (2019) conducted a cohort in Cardiovascular mortality (n=489). LRP1 T/T or C/T genotype vs. LRP1 C/C genotype was evaluated on Cardiovascular mortality (females) (HR 5.61, 95% CI 1.98-15.85, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: